Browse
Submit Data
Databases
API
Help

Dataset Information

15 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya.

ABSTRACT: Observed SARS-CoV-2 infections and deaths are low in tropical Africa raising questions about the extent of transmission. We measured SARS-CoV-2 IgG by ELISA in 9,922 blood donors across Kenya and adjusted for sampling bias and test performance. By 1st September 2020, 577 COVID-19 deaths were observed nationwide and seroprevalence was 9.1% (95%CI 7.6-10.8%). Seroprevalence in Nairobi was 22.7% (18.0-27.7%). Although most people remained susceptible, SARS-CoV-2 had spread widely in Kenya with apparently low associated mortality.

SUBMITTER: Adetifa IMO

PROVIDER: S-EPMC8233334 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020.

Project description: Not available

| S-EPMC8014239 | biostudies-literature

Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.

Project description: Not available

| S-EPMC7685039 | biostudies-literature

SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.

Project description: Not available

| S-EPMC8013879 | biostudies-literature

The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review.

Project description: Not available

| S-EPMC8562786 | biostudies-literature

First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.

Project description: Not available

| S-EPMC9277990 | biostudies-literature

Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves.

Project description: Not available

| S-EPMC9045619 | biostudies-literature

Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.

Project description: Not available

| S-EPMC8639096 | biostudies-literature

Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City.

Project description: Not available

| S-EPMC8136714 | biostudies-literature

Trancriptome analysis of peripheral leukocytes from SARS-CoV-2 infected patients and healthy uninfected individuals during the first wave of COVID-19 pandemic in Brazil

Project description:To evaluate the gene expression profiling of peripheral leukocytes in different outcomes of SARS-CoV-2 infections, whole blood samples were collected from individuals with positive SARS-CoV-2 nasopharyngeal swab by RT-PCR (54 patients) and healthy uninfected individuals (12 volunteers). Infected patients were classified into mild, moderate, severe and critical groups according to a modified statement in the Novel Coronavirus Pneumonia Diagnosis and Treatment Guideline. Blood were collected into EDTA tubes and the buffy coat samples were stored in TRIzol reagent at -80 °C until use for RNA extraction. Affymetrix Clariom S array was used to perform the high-throughput gene expression profiling. Microarray analyses were performed using APT Affymetrix software, R packages and Bioconductor libraries. This systemic view of SARS-CoV-2 infections through blood transcriptomics will foster the understanding about molecular mechanisms and immunopathological processes involved in COVID-19 disease and its different outcomes.

2022-04-29 | E-MTAB-11240 | biostudies-arrayexpress

Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China.

Project description: Not available

| S-EPMC7603985 | biostudies-literature